Logo image of BABY.CA

ELSE NUTRITION HOLDINGS INC (BABY.CA) Stock Fundamental Analysis

TSX:BABY - Toronto Stock Exchange - CA2902571041 - Common Stock - Currency: CAD

0.02  +0.01 (+33.33%)

Fundamental Rating

2

Overall BABY gets a fundamental rating of 2 out of 10. We evaluated BABY against 18 industry peers in the Food Products industry. While BABY seems to be doing ok healthwise, there are quite some concerns on its profitability. BABY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BABY had negative earnings in the past year.
BABY had a negative operating cash flow in the past year.
In the past 5 years BABY always reported negative net income.
In the past 5 years BABY always reported negative operating cash flow.
BABY.CA Yearly Net Income VS EBIT VS OCF VS FCFBABY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -155.69%, BABY is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -314.47%, BABY is doing worse than 72.22% of the companies in the same industry.
Industry RankSector Rank
ROA -155.69%
ROE -314.47%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BABY.CA Yearly ROA, ROE, ROICBABY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

BABY has a worse Gross Margin (2.20%) than 88.89% of its industry peers.
The Profit Margin and Operating Margin are not available for BABY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BABY.CA Yearly Profit, Operating, Gross MarginsBABY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

5

2. Health

2.1 Basic Checks

BABY does not have a ROIC to compare to the WACC, probably because it is not profitable.
BABY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BABY.CA Yearly Shares OutstandingBABY.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
BABY.CA Yearly Total Debt VS Total AssetsBABY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

BABY has an Altman-Z score of -12.13. This is a bad value and indicates that BABY is not financially healthy and even has some risk of bankruptcy.
BABY's Altman-Z score of -12.13 is on the low side compared to the rest of the industry. BABY is outperformed by 83.33% of its industry peers.
BABY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.13
ROIC/WACCN/A
WACC7.91%
BABY.CA Yearly LT Debt VS Equity VS FCFBABY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 1.83 indicates that BABY should not have too much problems paying its short term obligations.
BABY's Current ratio of 1.83 is amongst the best of the industry. BABY outperforms 88.89% of its industry peers.
BABY has a Quick Ratio of 1.83. This is a bad value and indicates that BABY is not financially healthy enough and could expect problems in meeting its short term obligations.
BABY has a better Quick ratio (0.52) than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 0.52
BABY.CA Yearly Current Assets VS Current LiabilitesBABY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

BABY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.57%, which is quite good.
The Revenue has decreased by -5.02% in the past year.
Measured over the past years, BABY shows a very strong growth in Revenue. The Revenue has been growing by 84.94% on average per year.
EPS 1Y (TTM)19.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-607.45%
Revenue 1Y (TTM)-5.02%
Revenue growth 3Y84.94%
Revenue growth 5YN/A
Sales Q2Q%4.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year104.16%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BABY.CA Yearly Revenue VS EstimatesBABY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BABY.CA Yearly EPS VS EstimatesBABY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BABY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BABY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BABY.CA Price Earnings VS Forward Price EarningsBABY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BABY.CA Per share dataBABY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BABY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELSE NUTRITION HOLDINGS INC

TSX:BABY (6/16/2025, 7:00:00 PM)

0.02

+0.01 (+33.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-31 2025-03-31/bmo
Earnings (Next)07-19 2025-07-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.98%
Ins Owner ChangeN/A
Market Cap6.24M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.03
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -155.69%
ROE -314.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.2%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.73%
Cap/Sales 0.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 0.52
Altman-Z -12.13
F-Score4
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)36.11%
Cap/Depr(5y)63.02%
Cap/Sales(3y)2.69%
Cap/Sales(5y)6.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-607.45%
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.02%
Revenue growth 3Y84.94%
Revenue growth 5YN/A
Sales Q2Q%4.66%
Revenue Next Year104.16%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.59%
OCF growth 3YN/A
OCF growth 5YN/A